MAY 2–4, 2019

Advanced Course in Cytoreductive Surgery for Ovarian Cancer and Peritoneal Surface Malignancies: Radical Pelvic and Upper Abdominal Procedure with Cadaver Dissection

Surf & Sand Resort

1555 South Coast Highway, Laguna Beach, CA 92651

www.ovariancancer.uci.edu/cytoreductive-cme

2019 Course Director

Robert E. Bristow, MD, MBAChair, Department of Obstetrics and Gynecology The Philip J. DiSaia Chair in Gynecologic Oncology UCI School of Medicine

UCI Health Faculty

Krishnansu S. Tewari, MDProfessor, Division of Gynecologic Oncology Interim Director Division of Gynecologic Oncology Department of Obstetrics and Gynecology UCI School of Medicine

Leslie M. Randall, MDAssociate Professor, Division of Gynecologic Oncology Department of Obstetrics and Gynecology UCI School of Medicine

Fabio Cappuccini, MD Clinical Professor Department of Obstetrics and Gynecology UCI School of Medicine

Kristine R. Penner, MD, MPHAssistant Professor, Division of Gynecologic Oncology Department of Obstetrics and Gynecology UCI School of Medicine

David K. Imagawa, MD, PhDChief, Division of Hepatobiliary and Pancreas Surgery and Islet Cell Transplantation Professor, Clinical Surgery and Pathology Department of Surgery UCI School of Medicine

Zeljka Jutric, MD Assistant Professor -- Department of Surgery, Division of Hepatobiliary and Pancreas Surgery and Islet Cell Transplantation UCI School of Medicine

Ronald F. Wolf, MD Professor, Department of Surgery, Division of Hepatobiliary and Pancreas Surgery UCI School of Medicine

Guest Faculty

Ahmed N. Al-Niaimi, MDUniversity of Wisconsin School of Medicine and Public Health Madison, WI

Dennis S. Chi, MDMemorial Sloan Kettering Cancer Center, New York City, NY

William A. Cliby, MDMayo Clinic, Rochester, MN

Marcela G. del Carmen, MD, MPHHarvard Medical School and Massachusetts General Hospital, Boston, MA

Ramez N. Eskander, MDUniversity of California, San Diego, San Diego, CA

Christina Fotopoulou, MD, PhDImperial College of London Healthcare NHS Trust, Queen Charlotte’s and Chelsea Hospital, London, United Kingdom

Oliver Zivanovic, MD, PhDMemorial Sloan Kettering Cancer Center, New York City, NY

Jula Veerapong, MDUniversity of California, San Diego, San Diego, CA

Advanced Course in Cytoreductive Surgery for Ovarian Cancer and Peritoneal Surface Malignancies: Radical Pelvic and Upper Abdominal Procedure with Cadaver Dissection

Purpose of the CourseThe thoroughness of cytoreductive surgery is a primary contributor to survival for patients with advanced ovarian and primary peritoneal carcinoma. This program is designed to provide information through formal lectures, panel discussions and cadaver dissection about clinical applications of advanced cytoreductive surgery for ovarian cancer and related gynecologic peritoneal surface malignancies.

Target AudienceThis activity is designed for physicians and surgeons who practice the specialty of gynecologic oncology and surgical oncology.

Learning ObjectivesAfter completing the learning activity, the participant should be able to:

• Describe the prognostic impact of minimal residual disease achievable through advanced cytoreductive surgical procedures.

• Discuss the advantages, limitations and indications for advanced cytoreductive surgery in gynecological practice.

• Describe the critical steps in performing advanced cytoreductive surgical procedures in gynecology.

RegistrationRegistration for the course is available at www.ovariancancer.uci.edu/cytoreductive-cme To ensure a spot in this course, early registration is strongly encouraged.

Course Registration FeesPhysicians and Surgeons - $1,950 Fellows and Residents - $1,450

Registration fees include both days of the conference, the evening reception, continental breakfast, lunch and CME certificate. For more information, contact Jenille Powers at 714-456-5968 or japowers@uci.edu

Accreditation StatementThe University of California, Irvine School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation StatementThe University of California, Irvine School of Medicine designates this live activity of a maximum of 15.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Statement

It is the policy for the University of California, Irvine School of Medicine and University of California CME consortium to ensure balance, independence, objectivity and scientific rigor in all CME activities. Full disclosure or conflict and resolution will be made in writing via handout materials of syllabus.

AccommodationsSurf & Sand Resort 1555 South Coast Highway, Laguna Beach, CA 92651 800-837-9230 | www.surfandsandresort.com

Special discounted hotel room rates on the beach will be available for early booking as space is limited. We recommend making travel arrangements early. A room rate of $295 a night is guaranteed for conference attendees through March 15, 2019. Contact the hotel directly for reservations at 800-837-9230. Be sure to state that you are attending the UC Irvine Health course in Cytoreductive Surgery. All attendees are responsible for their own reservations. The standard hotel individual reservation cancellation policy will apply.

California Assembly Bill 1195This activity is in compliance with California Assembly Bill 1195 which requires continuing medical education activities with patient care components to include curriculum in the subjects of cultural and linguistic competency. For specific information regarding Bill 1195 and definitions of cultural and linguistic competency, please visit the CME website at www.meded.uci.edu/CME.

ADA StatementIn compliance with the Americans with Disabilities Act, we will make every reasonable effort to accommodate your needs. For any special requests, please contact Jenille Powers at 714-456-5968 or japowers@uci.edu on or before March 15, 2019.

UCI Health Faculty

CS 2483 6/18

6:45–7:30 a.m. Breakfast

7:30–7:45 a.m. Welcome and introduction (Bristow)

7:45–8:30 a.m. Cytoreductive Surgery: History & Rationale (Tewari)

8:30–9 a.m. Triage Between Initial Surgery or Chemotherapy (del Carmen)

9–9:30 a.m. Pre-operative Preparation & Postoperative Care (Eskander)

9:30–10:15 a.m. Surgical Armamentarium & Strategic Approach (Bristow)

10:15–10:30 a.m. Break

10:30–11:30 a.m. Radical Oophorectomy & the Rectosigmoid Colectomy (Bristow/Fotopoulou)

11:30–12:15 p.m. Liver, Gallbladder, Porta Hepatis (Imagawa)

12:15–1 p.m. Lunch

1–1:30 p.m. Morison’s Pouch, Lesser Sac & Lesser Omentum (Veerapong)

1:30–2:30 p.m. Diaphragm & Thoracic Surgery (Chi/Al-Niaimi)

2:30–3 p.m. Surgical Video Session (Zivanovic)

3 p.m. Adjourn

6 p.m. Group dinner

6:45–7:30 a.m. Breakfast

7:30–8:15 a.m. Pelvic & Para-aortic Adenopathy (Eisenkop)

8:15–9 a.m. Celiac Axis, Nephrectomy, Adrenalectomy (Al-Niaimi)

9–10 a.m. Spenectomy, Distal Pancreatectomy & Multivisceral Resection (Cliby/Bristow)

10–10:15 a.m. Break

10:15–11 a.m. Enhanced Recovery After Surgery & “Red Rules” (Cliby/Chi)

11–11:45 a.m. Extrapelvic Bowel Surgery & Management of Obstruction (Fotopoulou)

11:45–12:15 p.m. MIS Application & Intraoperative Imaging (Randall)

12:15–1:30 p.m. Lunch

1:30–1:45 p.m. Sugarbaker Peritonectomy Procedures & Carcinomatosis Indices (Veerapong)

1:45–2:30 p.m. HIPEC (Zivanovic)

2:30–3 p.m. Ovarian Cancer: State of the Science (Tewari)

3 p.m. Adjourn

5–6:30 p.m. Cocktail reception

6:30 p.m. Open

THU

RSD

AY

MA

Y 2FR

IDA

Y M

AY 3

6:30–7:15 a.m. Breakfast

7:15–8 a.m. Transit to UC Irvine Medical Center lab

8–11:30 a.m. Session 1: HIPEC, Right & Left Upper Abdomen

11:30–12:15 p.m. Lunch

12:15–3:45 p.m. Session 2: Abdominal Retroperitoneum, Bowel Surgery, Pelvis

4 p.m. Adjourn

SATU

RD

AY

MA

Y 4